Central Glass CO., LTD.

Form 483 issued September 15, 2023 · UBE, Japan

Inspection
Sep 11 – Sep 15, 2023
Investigator
Teresa I. Navas
Observations
6
Pages
5
FEI number
3002806649

In short: On September 15, 2023, FDA issued a Form 483 with 6 observations to Central Glass CO., LTD. in UBE, YAMAGUCHI (FEI 3002806649) after an inspection that ran Sep 11 – Sep 15, 2023. The investigator was Teresa I. Navas. Most observations concern laboratory controls and production; the most-cited regulation is 21 CFR 211.160 (general requirements).

At a glance

Laboratory controls and production account for 4 of 6 observations.

Laboratory controls2
Production2
Facilities & equipment1
Materials1

Most cited: 21 CFR 211.160 (2×) · 211.100 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Laboratory Controls are…

  2. 02

    Specifications of Water used in the manufacture of APIs do not demonstrate the water is suitable…

  3. 03

    Your cleaning procedures are…

  4. 04

    Changes that could affect the production and control of the intermediate or API are not always…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Central Glass CO., LTD.?

FDA listed 6 observations on this Form 483, mostly about laboratory controls, production and facilities & equipment. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.

Who inspected Central Glass CO., LTD.?

Teresa I. Navas is named on this Form 483, for the inspection of Sep 11 – Sep 15, 2023. Each investigator has a profile showing what they cite most.

When was Central Glass CO., LTD. inspected by FDA?

The inspection ran Sep 11 – Sep 15, 2023, and the Form 483 is dated September 15, 2023.

How do I get the full Form 483 for Central Glass CO., LTD.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free